← Back to patent-cliff list
IG-RD-001
Tier C — Watch / tradeIG-RD-001
Zeller
Originator
2002
First approval
-
Expiry (public)
No sales data
Peak sales
Natural product / extract
Type
Targets：Leukotriene
Brand：Tesalin
Indications (approved)：Allergic rhinitis
Regional status
US
-
EU
Approved
2002-01-01
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of IG-RD-001?
Approved indications include: Allergic rhinitis.
When does the IG-RD-001 patent expire?
No public expiry year is available for IG-RD-001 yet; this page updates once verified.
How do I get a quote for IG-RD-001 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-27